Karuna Labs Secures $3 Million in Seed Funding; Hires Top Medical and Tech Talent to Further Treatment of Chronic Pain with VR

SAN FRANCISCO, Sept. 10, 2019 /PRNewswire/ — Karuna Labs, creator of personalized functional restoration and chronic pain management programs using Virtual Reality (VR) technology to retrain the brain, today announces $3 million in seed funding, led by Baseline Ventures, with investments from Anorak Ventures, the AET Fund, the Hustle Fund, Correlation Ventures, and Dreamit Ventures.

Karuna Labs is using immersive virtual reality technology to tackle the critical and debilitating health issue of chronic pain, without the need for opioid pain relief or the need for costly invasive surgeries,” said Steve Anderson, Founder of Baseline Ventures. “We’re proud of this innovative team comprised of medical and technology professionals who’ve come together to expand the reach and impact on the neurorehabilitation industry.”

In addition to supporting Karuna Labs’ clinical validation, the funding will be used to further develop the technology and the team. The company has recently added industry experts from the medical and gaming industries to its team, including Dr. James Petros, Chief Medical Officer, and Andy Riedel, Chief Technology Officer.

Dr. Petros specializes in interventional pain management and musculoskeletal care and is triple board-certified in Physical Medicine & Rehabilitation (Physiatry), Pain Medicine, and Regenerative Medicine, and brings his expertise in comprehensive pain and injury management to Karuna Labs. He is also the founder and CEO of Allied Pain & Spine Institute.

Riedel is a 30-year gaming industry veteran and has spent his career creating immersive experiences, games, and communities, as well as highly scalable server infrastructure for both mobile and web at companies including PlayStudios, Kabam, and Zynga.

“These important milestones continue to solidify our leading role in changing how chronic pain is treated and patients’ ability to regain their quality of life,” said Lincoln Nguyen, CEO of Karuna Labs. “We’re establishing a new first line of defense against chronic pain and remain focused on the lives we’re able to change through our technology while reducing the need for invasive procedures and opioid dependence.”

For more information about Karuna Labs, visit www.karunalabs.com.

About Karuna Labs:
Karuna Labs creates personalized chronic pain management programs using Virtual Reality (VR) technology that retrains the brain to perceive movement as non-threatening. Designed to restore function, Karuna Pro is used in clinics around the country, while Karuna Home is offered direct-to-patients for home use through workers’ compensation insurance.

Founded by neuroscientist turned VR engineer Lincoln Nguyen, Karuna Labs focuses on improving the patient’s quality of life by helping them better adhere to their plans of care and improving their ranges of motion. For more information, visit www.karunalabs.com or email info@karunalabs.com  

View original content:http://www.prnewswire.com/news-releases/karuna-labs-secures-3-million-in-seed-funding-hires-top-medical-and-tech-talent-to-further-treatment-of-chronic-pain-with-vr-300914512.html

SOURCE Karuna Labs

Staff

Recent Posts

Olympian Gabby Thomas Draws Crowd at Wellness Event with BetterWay(TM) Blood Testing at H-E-B SoCo

Guests had an opportunity to meet Gabby Thomas, win health-focused prizes, and learn simple ways…

5 hours ago

UOG (United One Group) Wins Three Prestigious Industry Awards at CES 2026

CES Official Spokesperson Highlights UOG Featured ProductsIntroducing the World's First Black Diamond Carbon & Nano…

14 hours ago

Best Ipamorelin vs Sermorelin: Growth Hormone Peptide Comparison 2026 — ReadyRx Prescription Telehealth Analysis

Independent research summary reviews mechanisms, regulatory considerations, and telehealth access pathways as consumers compare growth…

17 hours ago

GLP-1 Booster From Health Journey: 2026 Ingredient Analysis And Probiotic Metabolic Support Explained

Examining Akkermansia Muciniphila, Clostridium Butyricum, And The Gut Microbiome Research Behind This Probiotic GLP-1 Supplement…

17 hours ago

MEDVi GLP-1 Investigation: What Consumer Data Shows About Compounded Telehealth Weight Loss Programs

Independent Analysis Examines MEDVi's Semaglutide Medication Model, FDA Compounding Framework, and Prescription Accessibility Trends Heading…

17 hours ago